Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Pakistan Journal of Medicine and DentistryOpen Access

Insights into Dengue Vaccine Development: Highlighting Serotype Diversity, Safety Concerns, and the Promise of AI

View Full Paper
Ask AI
Bookmark
Share

Authors

SNSitara NasarHKHafiz Muhammad Haseeb Khaliq

Discussion

Loading...

Member takes

Overview

Observational analysis highlights vaccine effectiveness and safety concerns in dengue populations, suggesting AI can enhance development strategies.

Key Points

  • Vaccine performance varies due to dengue serotype diversity and risks linked to antibody-dependent enhancement.
  • TAK-003 shows efficacy of 85.9% against hospitalization, underscoring the importance of careful deployment in seronegative individuals.
  • Current research incorporates AI-based strategies for real-time genomic surveillance and predictive modeling to improve vaccine safety.
  • Engaging new technologies and rigorous science can drive a path toward an effective and equitable dengue vaccine.

Cite This Study

Nasar et al. (2025) studied this question.

synapsesocial.com/papers/68dd89defe798ba2fc497d26https://doi.org/10.36283/ziun-pjmd14-4/001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advancement of Dengue Virus Vaccine: Progress and Challenges2024
  2. 2State of the Art on Vaccine Development Against Dengue Infection: Scoping Review of the Literature2025
  3. 3Dengue Vaccines in a Changing Epidemiological Landscape: Current Evidence, Unresolved Challenges, and Public Health Considerations2026
  4. 4Dengue Vaccines: Current Status and Future Perspectives2024 · 5 citations
  5. 5Challenges and Opportunities in the Development of Dengue Vaccines: A Comprehensive Review2026 · 1 citations